Innovative Bioink Technology Revolutionizes 3D Printing of Blood Vessels
November 28, 2024 - 06:05
Researchers at the University of Twente, Netherlands, have made an advancement in bioprinting technology that could transform how we create vascularized tissues. Their innovative bioink enables precise 3D printing of blood vessels, paving the way for significant improvements in regenerative medicine and tissue engineering. This breakthrough could lead to enhanced methods for developing artificial organs and improving transplant success rates. The technology utilizes DNA-based materials to create a more accurate and functional representation of vascular structures, which are crucial for supplying nutrients and oxygen to tissues. As this research progresses, it holds the potential to greatly impact healthcare and the future of medical treatments.
MORE NEWS
July 20, 2026 - 03:13
Micron Technology (NASDAQ:MU) falls 13% as market focuses on AI investment prospectsMicron Technology saw its stock price plunge 13% on Wednesday as Wall Street shifted its attention to the company`s long-term artificial intelligence investment outlook. The memory chip maker, a...
July 19, 2026 - 01:16
Letter | Doubts about nuclear fusion technologyDear Editor: Will Briggs`s article on Realta Fusion`s plans to build a commercial nuclear fusion research facility at the former Oscar Mayer plant reminded me that I worked on the Tokamak Fusion...
July 18, 2026 - 05:58
Cognizant Technology Solutions (CTSH) Expands AI And Cyber Push, Is The 37% Undervaluation Real?Cognizant Technology Solutions is making a bigger bet on artificial intelligence and cybersecurity. The company recently joined OpenAI`s Daybreak Cyber Partner Program, expanded its Gemini...
July 17, 2026 - 18:59
Roundtable Secures Enterprise Technology Platform Partnership with Mario Nawfal, the World’s #1 Most-Viewed JournalistLONDON, July 17, 2026 (GLOBE NEWSWIRE) -- Roundtable, the AI-powered and DeFi-enabled enterprise media platform listed on Nasdaq under the ticker RTB, has announced a major technology partnership...